Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Potential new treatments for asthma from Roche act as chemokine receptor antagonists

July 4, 2000

PathoGenesis begins clinical trial of TOBI in patients with severe bronchiectasis

July 4, 2000

AWD-12-343 compares favorably with known PDE4 inhibitors in model of lung inflammation

June 30, 2000

Selective PDE4 inhibitors with bronchodilating, antiinflammatory properties

June 29, 2000

United Therapeutics discontinues UT-77 development project

June 28, 2000

Use of seratrodast for COPD supported by clinical results

June 28, 2000

Roche presents 4-aroylpiperidines active as chemokine receptor antagonists

June 28, 2000

Icos acquires additional rights to Abbott's LFA-1 compounds

June 27, 2000

F-1322 dropped from development after reaching phase II

June 27, 2000

Eotaxin found to regulate gastrointestinal allergic reactions

June 27, 2000

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...